ArticleFrontiers in pharmacology2023

Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety.

M T Corasaniti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.